JANE STREET GROUP, LLC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$305,861
-79.9%
85,436
-79.2%
0.00%
-100.0%
Q2 2023$1,518,870
+3026.9%
411,618
+2704.9%
0.00%
Q1 2023$48,574
-92.9%
14,675
-91.7%
0.00%
Q4 2022$682,337
+488.2%
175,860
+267.6%
0.00%
Q3 2022$116,000
+300.0%
47,838
+226.9%
0.00%
Q2 2022$29,000
-97.5%
14,633
-97.7%
0.00%
Q1 2022$1,143,000
+618.9%
624,366
+455.6%
0.00%
Q4 2021$159,000
+160.7%
112,387
+108.5%
0.00%
Q3 2021$61,000
-48.3%
53,906
-26.9%
0.00%
Q2 2021$118,000
+195.0%
73,777
+226.3%
0.00%
Q1 2021$40,000
-16.7%
22,612
+12.7%
0.00%
Q3 2020$48,000
+60.0%
20,056
+92.8%
0.00%
Q2 2020$30,000
-70.6%
10,400
-70.6%
0.00%
Q1 2020$102,000
-84.4%
35,333
-78.4%
0.00%
-100.0%
Q4 2019$654,000
+9.4%
163,491
+21.7%
0.00%0.0%
Q3 2019$598,000
+164.6%
134,295
+130.1%
0.00%
Q2 2019$226,000
+27.7%
58,374
+25.1%
0.00%
Q1 2019$177,00046,6630.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$15,520,00013.71%
Stonepine Capital Management, LLC 6,940,000$26,927,20011.33%
Caligan Partners LP 2,676,093$10,383,2418.64%
Altium Capital Management LP 2,870,000$11,135,6005.66%
AWM Investment Company, Inc. 6,015,000$23,338,2003.36%
EAM Investors, LLC 1,749,598$6,788,4401.40%
Perceptive Advisors 11,900,255$46,172,9891.30%
EAM Global Investors LLC 836,323$3,244,9330.84%
Potomac Capital Management, Inc. 120,000$4660.54%
OBERWEIS ASSET MANAGEMENT INC/ 536,900$2,083,1720.44%
View complete list of ADMA BIOLOGICS INC shareholders